675616-37-2

Upstream product

• 100-39-0 benzyl bromide 
• 99-24-1 methyl galloate 
• 70424-94-1 methyl 3,4,5-tris(benzyloxy)benzoate 

Downstream Products

• 675616-38-3 (E)-methyl 2-(1-octen-1-yl)-3,4,5-tribenzyloxybenzoate 
• 219781-78-9 methyl 3,4,5-tribenzyloxy-2-(2,3-dibenzyloxy-5-methoxycarbonylphenoxy)benzoate 
• 1606148-46-2 methyl 3,4,5-tribenzyloxy-2-(2,3-dimethoxy-5-methoxycarbonylphenoxy)benzoate 
• 1606148-47-3 methyl 3,4,5-tribenzyloxy-2-(2,3-ethoxymethylenedioxy-5-methoxycarbonylphenoxy) benzoate 
• 1606148-48-4 methyl 2-(2,3-benzyloxy-5-methoxycarbonylphenoxy)-3,4,5-tribenzyloxybenzoate 
• 1606148-49-5 methyl 3,4,5-tribenzyloxy-2-(2,3-p-methoxybenzyloxo-5-methoxycarbonylphenoxy) benzoate 
• 1676106-70-9 C₄₂H₃₂O₁₀ 
• 5693-34-5 dehydrodigallic acid 
• 476-66-4 ellagic acid 
• 70424-94-1 methyl 3,4,5-tris(benzyloxy)benzoate 
• 97152-19-7 dimethyl 4,4',5,5',6,6'-hexakis(benzyloxy)-[1,1'-biphenyl]-2,2'-dicarboxylate 
• 1034402-65-7 3,4,5-tris(benzyloxy)-2-bromobenzoic acid 

Relevant academic research and scientific papers

Synthetic Ellagic Acid Glycosides Inhibit Early Stage Adhesion of Streptococcus agalactiae Biofilms as Observed by Scanning Electron Microscopy

Ellagic acid derivatives possess antimicrobial and antibiofilm properties across a wide-range of microbial pathogens. Due to their poor solubility and ambident reactivity it is challenging to synthesize, purify, and characterize the activity of ellagic acid glycosides. In this study, we have synthesized three ellagic acid glycoconjugates and evaluated their antimicrobial and antibiofilm activity in Streptococcus agalactiae (Group B Streptococcus, GBS). Their significant impacts on biofilm formation were examined via SEM to reveal early-stage inhibition of cellular adhesion. Additionally, the synthetic glycosides were evaluated against five of the six ESKAPE pathogens and two fungal pathogens. These studies reveal that the ellagic acid glycosides possess inhibitory effects on the growth of gram-negative pathogens.

Synthesis and biological profiling of tellimagrandin I and analogues reveals that the medium ring can significantly modulate biological activity

A novel synthesis of the ellagitannin natural product tellimagrandin I and a series of medium ring analogues is described. These compounds were all subsequently screened for redox activity, ability to precipitate protein and cellular phenotype in HeLa cel

Total synthesis of sanguiin H-5

(Chemical Equation Presented) Using an atropdiastereoselective oxidative biaryl coupling as the key step, the total synthesis of the ellagitannin natural product sanguiin H-5 is reported. Both organomagnesium and organozinc based metalation methodologies

OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING -AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME

The present invention provides a chiral phase-transfer catalyst of the following formula (I): The compound (I) can be produced by reacting a 2,2'-dimethylene bromide-1,1'-biphenyl derivative, which can be produced through comparatively small number of steps, with an easily available secondary amine.

Synthetic racemate and enantiomers of cytosporone E, a metabolite of an endophytic fungus, show indistinguishably weak antimicrobial activity

The racemate and the enantiomers of cytosporone E [3-heptyl-4,5,6- trihydroxyphthalide (1)], a metabolite of the endophytic fungus, CR200 (Cytospora sp.), were synthesized. The key steps were (i) Sharpless asymmetric dihydroxylation of an alkene (8) and (